297 related articles for article (PubMed ID: 16924566)
1. [MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma].
Calikoğlu M; Unlü A; Tamer L; Ozgür E
Tuberk Toraks; 2006; 54(2):114-21. PubMed ID: 16924566
[TBL] [Abstract][Full Text] [Related]
2. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
3. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
[TBL] [Abstract][Full Text] [Related]
4. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
Kong YJ; Sun WX; Zhang YM; Shi YZ
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
[TBL] [Abstract][Full Text] [Related]
5. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
[TBL] [Abstract][Full Text] [Related]
6. Clinical study of inflammatory factors in sputum induced early after lung volume reduction surgery.
Miao JB; Hou SC; Li H; Hu B; Wang TY
Chin Med J (Engl); 2008 Sep; 121(18):1796-9. PubMed ID: 19080360
[TBL] [Abstract][Full Text] [Related]
7. Induced sputum metalloproteinases and their inhibitors in relation to exhaled nitrogen oxide and sputum nitric oxides and other inflammatory cytokines in patients with chronic obstructive pulmonary disease.
Ziora D; Dworniczak S; Kozielski J
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():809-17. PubMed ID: 19218708
[TBL] [Abstract][Full Text] [Related]
8. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
Xu XM; Sun TY; Lin JB; Zhang HS
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
Xu L; Cai BQ; Zhu YJ
Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
[TBL] [Abstract][Full Text] [Related]
10. [Expressions of cyclooxygenase-2 and matrix metalloproteinase-2 and airflow obstruction in patients with chronic obstructive pulmonary disease].
Chen Y; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):324-7. PubMed ID: 15949313
[TBL] [Abstract][Full Text] [Related]
11. Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma.
Tanaka H; Miyazaki N; Oashi K; Tanaka S; Ohmichi M; Abe S
J Allergy Clin Immunol; 2000 May; 105(5):900-5. PubMed ID: 10808169
[TBL] [Abstract][Full Text] [Related]
12. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation.
Mercer PF; Shute JK; Bhowmik A; Donaldson GC; Wedzicha JA; Warner JA
Respir Res; 2005 Dec; 6(1):151. PubMed ID: 16372907
[TBL] [Abstract][Full Text] [Related]
13. Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma.
Matsumoto H; Niimi A; Takemura M; Ueda T; Minakuchi M; Tabuena R; Chin K; Mio T; Ito Y; Muro S; Hirai T; Morita S; Fukuhara S; Mishima M
Thorax; 2005 Apr; 60(4):277-81. PubMed ID: 15790981
[TBL] [Abstract][Full Text] [Related]
14. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
[TBL] [Abstract][Full Text] [Related]
15. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
16. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models].
Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602
[TBL] [Abstract][Full Text] [Related]
17. Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
Bolton CE; Stone MD; Edwards PH; Duckers JM; Evans WD; Shale DJ
Chron Respir Dis; 2009; 6(2):81-7. PubMed ID: 19411568
[TBL] [Abstract][Full Text] [Related]
18. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R
Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
[TBL] [Abstract][Full Text] [Related]
20. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
